The FDA approved 17 new molecular entities (NMEs) and two biological license applications in 2007, the lowest number of new approvals since 2002. Nine of the 19 approvals were the subject of priority review status, which is given to a drug for which few available treatments exist. Four of the new approvals were for oncology […]
The Chilean Economic Development Agency (CORFO) estimates that $100 million will be spent on R&D in the country during 2008 through InnovaChile, CORFO’s innovation department. If private industry meets government investment, total R&D funding could reach $200 million this year. The majority of funding will go to clusters recommended by the National Council of Innovation […]
Nitrogen is an essential component of proteins, as well as many other biomolecules, making it an important analyte for applications involving the quantification of organic materials. Although there are many general spectroscopic methods that can be used to identify nitrogen, two main methods are used in instruments designed for total nitrogen (TN) determination: the Kjeldahl […]
The January 31 issue of IBO reported on the analytical technologies used for biofuel research and production. In December 2007, a white paper on internationally compatible biofuel standards was published by a tripartite task force made up of biofuel experts, including those from Brazil’s National Institute of Metrology, Standardization, and Industrial Quality (INMETRO), the European […]
It was a familiar story in 2007 for the world’s major pharmaceutical companies. Patent expirations, a decline in new product introductions, and regulatory and cost hurdles were the name of the game. Following in the steps of Merck and Pfizer (see IBO 4/15/06, 2/15/07), a number of the large drug companies announced major cost cutting […]
As oil prices continue to hover near $100 a barrel and worldwide demand for energy shows no signs of slowing, it is clear that alternative fuel sources are a necessity. One of the most viable—and currently practical—alternative fuel sources is biofuels, including bioethanol and biodiesel, and government programs in the US and abroad are pursuing […]
A European assessment of drug research practices published in Regulatory Toxicology and Pharmacology has found that acute toxicity tests on animals are unnecessary. In Europe, slightly fewer than 500,000 rats and mice are used annually for toxicity testing. The report estimates that approximately 15,000 animals a year could be spared if the acute toxicity test […]
Although margins for US refineries plummeted between the first and second halves of 2007, a series of mergers and acquisitions are expected to take place during 2008. Large refiners and oil companies may begin selling their facilities in order to protect their bottom lines as prices for oil reach all-time highs. Smaller refiners, international firms […]
With the US Congress having completed its work for 2007 without reauthorizing the R&D tax credit, thousands of companies can expect tax increases in 2008. The R&D Credit Coalition estimates that the credit is equal to an average of six cents for every R&D dollar. Eleven thousand companies currently claim the credit, which saved businesses […]
The separations market far outperformed original estimates made at the beginning of last year. In fact, 2007 growth for the separations market was nearly two percentage points higher than the original forecast estimates. In 2007, the separations market accounted for $5.9 billion in sales and grew 7.1% over 2006, the fastest year over year growth […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
